Generics - Biosimilars

Filter

Current filters:

Biosimilars

Popular Filters

1240 to 1264 of 1269 results

Israeli generics giant Teva wins largest share of German health insurance AOK tenders

18-05-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s biggest generic drugmaker,…

EuropeGenericsMarkets & MarketingTeva Pharmaceutical Industries

US Medicare likely to run out of funds in 2024; Congressional Affordable Medicines Caucus

16-05-2011

The US Trustees of the Social Security and Medicare trust funds report on the current and projected financial…

GenericsHealthcareNorth AmericaPharmaceuticalPoliticsPricing

Dr Reddy’s launches Neulastim copy in India; doubles 4th-qtr profit

16-05-2011

Hyderabad, India-based generic drugmaker Dr Reddy’s Laboratories (NYSE: RDY) has launched its Peg-grafeel,…

Asia-PacificDr Reddy's LaboratoriesFinancialGenericsMarkets & MarketingNeulastimOncologyPeg-grafeelRoche

Australia clears way for increased access to generic medicines

13-05-2011

Australian consumers and health professionals will have more ready access to generic medicines following…

Asia-PacificGenericsHealthcarePatents

Teva 1st-qrt 2011 financials boosted by strong European sales

12-05-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s leading generics firm, reported…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Ranbaxy 1st-qtr 2011 net profit plunges 68% and sales fall 12%

11-05-2011

India’s largest drugmaker, Ranbaxy Laboratories RANB: BO), which is 64% owned by Japan’s Daiichi…

FinancialGenericsRanbaxy Laboratories

US FDA consults on user fee program for biosimilar and interchangeable biologicals

10-05-2011

The US Food and Drug Administration is requesting input from stakeholders and the public relating to…

BiotechnologyGenericsNorth AmericaPharmaceuticalRegulation

India set to become global leader in APIs industry

10-05-2011

Low-cost manufacturing facilities and abundant talent pool will drive the growth of India in the global…

Asia-PacificGenericsMarkets & Marketing

Growth in Canadian drug spending slows to lowest rate since 1996

09-05-2011

Although drugs remain an important cost driver in Canada’s health system, growth in spending has…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

Nigerian government plans local production of anti-malaria drugs

06-05-2011

To further reduce the cost of anti-malaria drug and reduce malaria incidence to the barest minimum, the…

GenericsMarkets & MarketingPharmaceuticalPoliticsRest of the WorldTropical diseases

Australian generic drugmakers welcome IP law to encourage R&D investment

06-05-2011

Members of Australia’s Generic Medicines Industry Association (GMiA) have strongly welcomed the…

Asia-PacificGenericsPatentsPharmaceutical

Chile remains on USTR Priority Watch list

06-05-2011

The Office of the United States Trade Representative (USTR) released its annual Special 301 Report on…

GenericsLegalNorth AmericaPatentsPharmaceuticalSouth America

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA

05-05-2011

Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Teva to buy Japanese generic drugmaker Taiyo?

04-05-2011

According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Mylan's 1st-qtr 2011 adjusted diluted EPS up 22%, in line with forecasts

04-05-2011

US generics group Mylan (Nasdaq: MYL) reported that total revenues for the quarter ended March 31, 2011…

FinancialGenericsMylan Laboratories

European Commission opens investigation against Cephalon and Teva

03-05-2011

The European Commission has opened a formal antitrust investigation to assess whether an agreement between…

CephalonEuropeGenericsLegalTeva Pharmaceutical Industries

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body

29-04-2011

The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years

28-04-2011

In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million

28-04-2011

USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of…

FinancialGenericsPharmaceuticalWatson Pharmaceuticals

1240 to 1264 of 1269 results

Back to top